Medical News

RSS

New study reviews latest scientific developments in autism

First consultant of child psychiatry in the UK reviews state of knowledge on autism. Despite substantial gains in knowledge and understanding of autism over the last three years, we are still no closer to either prevention or cure, according to Sir Michael Rutter, Professor of Developmental Psychopathology at the Institute of Psychiatry, King's College London.

2 Mar 2011

Four pharmaceutical companies partner to create new single-source industry

Four successful contract packaging and re-packaging companies in the pharmaceutical industry recently joined forces to create a new, single-source industry leader called Aphena Pharma Solutions.

2 Mar 2011

Study: Light-to-moderate alcohol consumption may decrease risk of dementia

Experts agree that long-term alcohol abuse is detrimental to memory function and can cause neuro-degenerative disease. However, according to a study published in Age and Ageing by Oxford University Press today, there is evidence that light-to-moderate alcohol consumption may decrease the risk of cognitive decline or dementia.

2 Mar 2011

Court case question: Who holds the patent — drug company or research institution

The invention of an AIDS test is a big deal, and it takes a lot of time, smarts and money to develop a good one. So there's a lot at stake in the legal tussle between Stanford University and the pharmaceutical giant Roche, with oral arguments opening Monday before the U.S. Supreme Court.

2 Mar 2011

EMD Serono receives FDA CRL on Cladribine Tablets NDA for relapsing-remitting multiple sclerosis

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) on the new drug application (NDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for relapsing-remitting multiple sclerosis (MS).

2 Mar 2011

CRT market in Europe to reach over €4.4 billion by 2017

According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the European cardiac rhythm management, electrophysiology and ablation market was valued at over €2.8 billion in 2010.

2 Mar 2011

Baxter announces European rMRP approval of PREFLUCEL seasonal influenza vaccine

Baxter International Inc. announced today the approval of a European repeat mutual recognition procedure (rMRP) by the Austrian Agency for Health and Food Safety for Baxter's PREFLUCEL seasonal influenza vaccine. The 13 participating European Union countries, including Germany, Spain, United Kingdom and Nordic countries, will formally implement the license on a national level to make PREFLUCEL available for the 2011-12 influenza season.

From Baxter International Inc. 2 Mar 2011

U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI

Oxygen Biotherapeutics, Inc. today announced it has received a $2.075 million, two-year grant from the U.S. Army to study the Company's proprietary Oxycyte PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury.

2 Mar 2011

Pluristem's PLX cells exhibit potential to treat accidental and intentionally induced muscle injuries

Pluristem Therapeutics, Inc. and the Berlin-Brandenburg Center for Regenerative Therapies (BCRT), in cooperation with the Charite - University of Medicine in Berlin,today announced the results of a pre-clinical study demonstrating that the local administration of PLX cells following muscle injury resulted in significant improvement in the recovery of muscle function when compared with the control group. This

2 Mar 2011

'Prehabilitation' exercise program can improve strength, functional ability before knee replacement surgery

A comprehensive "prehabilitation" exercise program for patients with severe knee arthritis can improve strength and functional ability before knee replacement surgery, reports a study in the February issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.

2 Mar 2011

Study: 700,000 drug-related ED visits cost nearly $1.4 billion in 2007

Over the past decade, drug-related poisonings have been on the rise in the United States. In fact, in many states drug-related poisoning deaths have now surpassed motor vehicle crash fatalities to become the leading cause of injury death. While the fatalities from this epidemic have been well reported, they are only the tip of the iceberg.

2 Mar 2011

Scientists use pioneering technology to create safer drinking water in the U.S.

Pioneering technology by scientists at Queen's University Belfast, which is transforming the lives of millions of people in Asia, is now being used to create safer drinking water in the United States.

2 Mar 2011

Health benefits of herbal teas no longer a folklore

Those who enjoy the caffeinated lift that comes from drinking traditional coffees and teas may tend to overlook the benefits of drinking herbal infusions. Now, as explained in this month's issue of Agricultural Research magazine, the idea that herbal teas may provide a variety of health benefits is no longer just folklore.

2 Mar 2011

Mathematical model predicts lifespan of stem cells

When patients receive a bone marrow transplant, they are getting a new population of hematopoietic stem cells. Fresh stem cells are needed when a patient is low on red blood cells, as in anemia, or white blood cells, which can be caused by cancer or even cancer treatments such as irradiation or chemotherapy. The problem is that a bone marrow transplant might not succeed because the transplanted stem cells don't live long enough or because they proliferate too well, leading to leukemia.

2 Mar 2011

Scientists discover how change in growth hormone activity leads to fatty liver disease

Scientists at the UCSF Cardiovascular Research Institute have discovered how a change in growth hormone activity in mice leads to fatty liver disease, a condition whose human counterpart is of rising concern worldwide.

2 Mar 2011

Obama Administration urges Florida Judge to clear up health law confusion

In its arguments for clarification from Federal District Court Judge Roger Vinson, the administration said this step is necessary so that they know how to proceed in defending the law and implementing its provisions.

2 Mar 2011

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.

2 Mar 2011

Study: Pycnogenol- offers natural solution for patients with metabolic syndrome

The American Heart Association estimates 35 percent of adults in the U.S. suffer from metabolic syndrome, a group of risk factors characterized by obesity and the simultaneous presence of heart disease risk factors with high blood pressure, blood sugar and lipids.

2 Mar 2011

Scientists discover signaling pathway in brain to induce cellular leptin resistance

Researchers at UT Southwestern Medical Center have identified a signaling pathway in the brain that's sufficient to induce cellular leptin resistance, a problem that decreases the body's ability to "hear" that it is full and should stop eating.

2 Mar 2011

Physician administered preventive dental program reduces tooth decay treatment among young children

A preventive dental program targeting preschoolers under age 4 administered by physicians instead of dentists effectively reduces the need for tooth decay-related treatment among young children, a University of North Carolina at Chapel Hill study shows.

2 Mar 2011

Medical News

New study reviews latest scientific developments in autism

Four pharmaceutical companies partner to create new single-source industry

Study: Light-to-moderate alcohol consumption may decrease risk of dementia

Court case question: Who holds the patent — drug company or research institution

EMD Serono receives FDA CRL on Cladribine Tablets NDA for relapsing-remitting multiple sclerosis

CRT market in Europe to reach over €4.4 billion by 2017

Baxter announces European rMRP approval of PREFLUCEL seasonal influenza vaccine

U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI

Pluristem's PLX cells exhibit potential to treat accidental and intentionally induced muscle injuries

'Prehabilitation' exercise program can improve strength, functional ability before knee replacement surgery

Study: 700,000 drug-related ED visits cost nearly $1.4 billion in 2007

Scientists use pioneering technology to create safer drinking water in the U.S.

Health benefits of herbal teas no longer a folklore

Mathematical model predicts lifespan of stem cells

Scientists discover how change in growth hormone activity leads to fatty liver disease

Obama Administration urges Florida Judge to clear up health law confusion

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Study: Pycnogenol- offers natural solution for patients with metabolic syndrome

Scientists discover signaling pathway in brain to induce cellular leptin resistance

Physician administered preventive dental program reduces tooth decay treatment among young children

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News